Evidence map›Paper›PMID 31806772›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020

Radiation Dosimetry in

Price A Jackson, Michael S Hofman, Rodney J Hicks, Mark Scalzo, John Violet

Abstract readClinical Trial
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Dosimetry of [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Pooled it
  2. Joint EANM/SNMMI procedure guideline for the use ofEuropean journal of nuclear medicine and molecular imaging · 2023
    Guideline
  3. Trial
  4. Review
  5. Outcome-driven dosimetry optimization for [European journal of nuclear medicine and molecular imaging · 2026
    Article
  6. Review
  7. Evolving SPECT-CT technology.The British journal of radiology · 2026
    Review
  8. Article
  9. Clinical value of per-treatment whole-body single-time-point automated dosimetry for [European journal of nuclear medicine and molecular imaging · 2026
    Article
  10. Article
  11. Fast [EJNMMI physics · 2026
    Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Characterization of Effective Half-Life for Instant Single-Time-Point Dosimetry Using Machine Learning.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  17. Article
  18. Article
  19. Impact of Posttreatment SPECT/CT on Patient Management DuringJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article
  20. Impact of the Reference Multiple-Time-Point Dosimetry Protocol on the Validity of Single-Time-Point Dosimetry for [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2024
    Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Price A JacksonDepartment of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia price.jackson@petermac.org.
Michael S HofmanDepartment of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.
Rodney J HicksDepartment of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.
Mark ScalzoDepartment of Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Australia.
John VioletDepartment of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calculation of radiation dosimetry in targeted nuclear medicine therapies is traditionally resource-intensive, requiring multiple posttherapy SPECT acquisitions. An alternative approach is to take advantage of existing pharmacokinetic data from these smaller cohorts to enable dose computation from a single posttreatment scan in a manner that may be applied to a much broader patient population.

Indexed as

Single Photon Emission Computed Tomography Computed TomographyDipeptidesHeterocyclic Compounds, 1-RingHumansLutetiumMaleNeoplasm MetastasisOrgan SpecificityProstate-Specific AntigenProstatic Neoplasms, Castration-ResistantRadioisotopesRadiometryTime FactorsDipeptidesHeterocyclic Compounds, 1-RingLutetiumLutetium-177Prostate-Specific AntigenPSMA-617Radioisotopes177Lu-PSMA-617image processingradiation dosimetryradiobiology

Identifiers

PMID31806772
PMCPMC7383083

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.